World Economic Forum 2023
Novartis leaders will be at the WEF Annual Meeting in Davos, Switzerland.
Novartis has announced an intention to separate the Sandoz business to create a standalone company by way of a 100% spin-off.
Sandoz announces agreement to acquire leading antifungal agent Mycamine® from Astellas, reinforcing hospital offering and leading Anti-Infectives portfolio
Novartis presents pivotal Phase III APPLY-PNH data at ASH demonstrating investigational oral monotherapy iptacopan superiority over anti-C5
Novartis receives European Commission approval for Pluvicto® as the first targeted radioligand therapy for treatment of progressive PSMA–positive metastatic castration-resistant prostate cancer
Novartis condemns the war in Ukraine and has been providing humanitarian support, financial donations as well as considerable volumes of medicines to those people impacted by the war.
Novartis resumes business in Ukraine
After studying current safety protocols in the country, and on advice which we will regularly review, we have begun to resume business operations remotely to help the war-torn country restore some basic critical business processes.
Novartis provides more than USD 25 million in medical aid to patients in Ukraine and bordering countries
Novartis condemns the war in Ukraine. The continued acts of unprovoked violence are harming innocent people, and this defies our mission to improve human health globally.
Our research redefines the way we understand disease and develop medicines. Discover the people and stories that make it possible.
Novartis in Society Integrated Report 2021
In 2021, we continued to reimagine medicine and deliver on our purpose to improve and extend people’s lives. See more in our Integrated Report.
Environmental, Social and Governance
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices.
Novartis COVID-19 Information Center
Novartis is responding to the coronavirus disease (COVID-19) outbreak. The information center provides a central hub for news, guidance and resources.
Live is the in-house magazine of Novartis which is now available in a digital format. Explore stories, podcasts and more from across the company.